| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Artificial sweeteners—do they bear a carcinogenic risk?
|
Weihrauch, M.R.
|
|
|
15 |
10 |
p. 1460-1465
|
artikel
|
| 2 |
Assessing prognosis in patients with chronic lymphocytic leukemia a quarter of a century after Rai and Binet staging systems
|
Montserrat, E.
|
|
|
15 |
10 |
p. 1450-1451
|
artikel
|
| 3 |
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience
|
Rodriguez, J.
|
|
|
15 |
10 |
p. 1504-1509
|
artikel
|
| 4 |
Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification
|
Savage, K.J.
|
|
|
15 |
10 |
p. 1467-1475
|
artikel
|
| 5 |
Clinical Bone Marrow and Blood Stem Cell Transplantation, 3rd edition
|
Michallet, A.-S.
|
|
|
15 |
10 |
p. 1579
|
artikel
|
| 6 |
Communication about the ending of anticancer treatment and transition to palliative care
|
Morita, T.
|
|
|
15 |
10 |
p. 1551-1557
|
artikel
|
| 7 |
Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
|
Spazzapan, S.
|
|
|
15 |
10 |
p. 1576
|
artikel
|
| 8 |
Gemcitabine and haemolytic-uraemic syndrome
|
Ruiz, I.
|
|
|
15 |
10 |
p. 1575-1576
|
artikel
|
| 9 |
Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance
|
Elias, D.
|
|
|
15 |
10 |
p. 1558-1565
|
artikel
|
| 10 |
hTERT expression and prognosis in B-chronic lymphocytic leukemia
|
Tchirkov, A.
|
|
|
15 |
10 |
p. 1476-1480
|
artikel
|
| 11 |
Metronomic therapy with cyclophosphamide induces rat lymphoma and sarcoma regression, and is devoid of toxicity
|
Rozados, V.R.
|
|
|
15 |
10 |
p. 1543-1550
|
artikel
|
| 12 |
New options and old dilemmas in the treatment of patients with advanced colorectal cancer
|
Punt, C.J.A.
|
|
|
15 |
10 |
p. 1453-1459
|
artikel
|
| 13 |
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group
|
Fountzilas, G.
|
|
|
15 |
10 |
p. 1517-1526
|
artikel
|
| 14 |
Paradoxical increases in serum IgM and viscosity levels following rituximab in Waldenstrom's macroglobulinemia
|
Treon, S.P.
|
|
|
15 |
10 |
p. 1481-1483
|
artikel
|
| 15 |
Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer
|
Chan, S.
|
|
|
15 |
10 |
p. 1527-1534
|
artikel
|
| 16 |
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression
|
Montoto, S.
|
|
|
15 |
10 |
p. 1484-1489
|
artikel
|
| 17 |
Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas
|
Faleiro-Rodrigues, C.
|
|
|
15 |
10 |
p. 1535-1542
|
artikel
|
| 18 |
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-fluorouracil and infusional 5-fluorouracil alone in advanced pancreatic carcinoma patients
|
Alliot, C.
|
|
|
15 |
10 |
p. 1576-1577
|
artikel
|
| 19 |
Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway
|
deGraffenried, L.A.
|
|
|
15 |
10 |
p. 1510-1516
|
artikel
|
| 20 |
Reply to Letter to the Editor on “The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer”, by G. Utkan, A. Büyükçelik, B. Yalçýn (Ann Oncol 2004; 15: 1574)
|
Tripathy, D.
|
|
|
15 |
10 |
p. 1574-1575
|
artikel
|
| 21 |
Response to the letter “Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU and infusional 5-FU alone in advanced pancreatic carcinoma patients”, by C. Allior (Ann. Oncol 2004; 15: 1576–1577)
|
Ducreux, M.
|
|
|
15 |
10 |
p. 1577-1578
|
artikel
|
| 22 |
Table of Contents
|
|
|
|
15 |
10 |
p. i-ii
|
artikel
|
| 23 |
The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer
|
Utkan, G.
|
|
|
15 |
10 |
p. 1574
|
artikel
|
| 24 |
The NHL-15 protocol for aggressive non-Hodgkin's lymphomas: a sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide† † A preliminary report of feasibility was presented at the American Society of Hematology, 1992, and published in Hem Onc Annals 1993 [14, 15].
|
Portlock, C.S.
|
|
|
15 |
10 |
p. 1495-1503
|
artikel
|
| 25 |
The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance
|
Sallah, S.
|
|
|
15 |
10 |
p. 1490-1494
|
artikel
|
| 26 |
Towards understanding the peripheral T-cell lymphomas
|
Armitage, J.O.
|
|
|
15 |
10 |
p. 1447-1449
|
artikel
|
| 27 |
Weekly paclitaxel combined with pegylated liposomal doxorubicin (Caelyx™) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors
|
Briasoulis, E.
|
|
|
15 |
10 |
p. 1566-1573
|
artikel
|
Tijdschrift beschrijving